Junmei Ye

702 total citations
27 papers, 431 citations indexed

About

Junmei Ye is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Junmei Ye has authored 27 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Physiology. Recurrent topics in Junmei Ye's work include Adipose Tissue and Metabolism (6 papers), Sirtuins and Resveratrol in Medicine (4 papers) and interferon and immune responses (3 papers). Junmei Ye is often cited by papers focused on Adipose Tissue and Metabolism (6 papers), Sirtuins and Resveratrol in Medicine (4 papers) and interferon and immune responses (3 papers). Junmei Ye collaborates with scholars based in China, Spain and United Kingdom. Junmei Ye's co-authors include Yubin Zhang, Daniel Sanchı́s, Fangrong Yan, Ruiyan Li, Liang Jin, Joan X. Comella, Miao Zhang, Zhe Li, Marta Llovera and Dandan Chen and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Cell Science.

In The Last Decade

Junmei Ye

26 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junmei Ye China 14 223 81 75 63 48 27 431
Xue-Fen Pang China 11 162 0.7× 102 1.3× 69 0.9× 54 0.9× 51 1.1× 13 468
Minglin Pan China 9 237 1.1× 55 0.7× 93 1.2× 39 0.6× 51 1.1× 13 426
Ke‐Xue Li China 12 207 0.9× 95 1.2× 63 0.8× 83 1.3× 59 1.2× 17 465
Xuanke Guan China 8 255 1.1× 75 0.9× 69 0.9× 83 1.3× 31 0.6× 16 413
Harsha Nagar South Korea 14 215 1.0× 39 0.5× 84 1.1× 78 1.2× 61 1.3× 31 441
Shengban You China 7 195 0.9× 79 1.0× 51 0.7× 39 0.6× 86 1.8× 8 413
Xiaowen Wang China 16 223 1.0× 103 1.3× 70 0.9× 97 1.5× 43 0.9× 37 566
Yuanyuan Tie China 7 230 1.0× 88 1.1× 55 0.7× 49 0.8× 40 0.8× 7 415

Countries citing papers authored by Junmei Ye

Since Specialization
Citations

This map shows the geographic impact of Junmei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmei Ye more than expected).

Fields of papers citing papers by Junmei Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junmei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmei Ye. The network helps show where Junmei Ye may publish in the future.

Co-authorship network of co-authors of Junmei Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Junmei Ye. A scholar is included among the top collaborators of Junmei Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junmei Ye. Junmei Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qi, et al.. (2024). The role of cGAS/STING signaling in ophthalmological diseases. Biomedicine & Pharmacotherapy. 177. 117078–117078.
2.
Chen, Jiawen, et al.. (2024). The role of cGAS-STING signaling in the development and therapy of head and neck squamous cell carcinoma. Frontiers in Immunology. 15. 1451305–1451305. 2 indexed citations
3.
Chen, Jiawen, Xinjia Ruan, Xiaozhi Xu, et al.. (2024). Cardiac injury activates STING signaling via upregulating SIRT6 in macrophages after myocardial infarction. Life Sciences. 341. 122474–122474. 6 indexed citations
4.
Chen, Jiawen, Qi Wang, Ruiyan Li, et al.. (2023). The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus. Life Sciences. 333. 122187–122187. 21 indexed citations
5.
Chen, Jiawen, Qi Wang, Ruiyan Li, et al.. (2023). The role of Keap1-Nrf2 signaling pathway during the progress and therapy of diabetic retinopathy. Life Sciences. 338. 122386–122386. 10 indexed citations
6.
Peng, Yue, Zhe Li, Jiawen Chen, et al.. (2022). SIRT6 regulates obesity-induced oxidative stress via ENDOG/SOD2 signaling in the heart. Cell Biology and Toxicology. 39(4). 1489–1507. 13 indexed citations
7.
Peng, Yue, et al.. (2022). IL-6 protects cardiomyocytes from oxidative stress at the early stage of LPS-induced sepsis. Biochemical and Biophysical Research Communications. 603. 144–152. 15 indexed citations
8.
Wang, Mengxiao, et al.. (2021). Obesity induced Ext1 reduction mediates the occurrence of NAFLD. Biochemical and Biophysical Research Communications. 589. 123–130. 2 indexed citations
9.
Chen, Dandan, Zhe Li, Miao Chen, et al.. (2019). Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1253–1264. 44 indexed citations
10.
11.
Yang, Shuai, Hui Xu, Fan Chen, et al.. (2017). AKT2 Blocks Nucleus Translocation of Apoptosis-Inducing Factor (AIF) and Endonuclease G (EndoG) While Promoting Caspase Activation during Cardiac Ischemia. International Journal of Molecular Sciences. 18(3). 565–565. 22 indexed citations
12.
Chen, Dandan, Yubin Zhang, Liang Jin, et al.. (2017). Interleukin-6 deficiency attenuates angiotensin II-induced cardiac pathogenesis with increased myocyte hypertrophy. Biochemical and Biophysical Research Communications. 494(3-4). 534–541. 25 indexed citations
13.
Chen, Dandan, Fan Chen, Yubin Zhang, et al.. (2017). AKT2 deficiency induces retardation of myocyte development through EndoG-MEF2A signaling in mouse heart. Biochemical and Biophysical Research Communications. 493(4). 1410–1417. 13 indexed citations
14.
Xia, Zheng, Yinhang Wang, Qilin Fan, et al.. (2017). Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis. European Journal of Pharmacology. 819. 161–168. 46 indexed citations
15.
Chen, Dandan, Shuai Yang, Zhe Li, et al.. (2017). Interleukin-6 deficiency facilitates myocardial dysfunction during high fat diet-induced obesity by promoting lipotoxicity and inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(12). 3128–3141. 34 indexed citations
16.
Ye, Junmei, Miriam Llorian, Anthony Rongvaux, et al.. (2013). A pathway involving HDAC5, cFLIP and caspases regulates expression of the splicing regulator polypyrimidine tract binding protein in the heart. Journal of Cell Science. 126(Pt 7). 1682–91. 22 indexed citations
17.
Ye, Junmei, et al.. (2012). Translation of Myocyte Enhancer Factor-2 is induced by hypertrophic stimuli in cardiomyocytes through a Calcineurin-dependent pathway. Journal of Molecular and Cellular Cardiology. 53(4). 578–587. 15 indexed citations
18.
Zhang, Jisheng, Junmei Ye, Núria Bahí, et al.. (2011). EndoG Links Bnip3-Induced Mitochondrial Damage and Caspase-Independent DNA Fragmentation in Ischemic Cardiomyocytes. PLoS ONE. 6(3). e17998–e17998. 28 indexed citations
19.
Ye, Junmei, et al.. (2009). Influence of paeonol on expression of COX-2 and p27 in HT-29 cells. World Journal of Gastroenterology. 15(35). 4410–4410. 16 indexed citations
20.
Tan, Shiyun, Junmei Ye, Cuijuan Qian, et al.. (2007). Paeonol inhibits the proliferation of human colorectal carcinoma cells and synergic with chemotherapeutic agents.. PubMed. 28(4). 642–3. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue-Fen Pang Breakdown of academic impact, for papers by Minglin Pan Breakdown of academic impact, for papers by Ke‐Xue Li Breakdown of academic impact, for papers by Xuanke Guan Breakdown of academic impact, for papers by Harsha Nagar Breakdown of academic impact, for papers by Shengban You Breakdown of academic impact, for papers by Xiaowen Wang Breakdown of academic impact, for papers by Yuanyuan Tie
Rankless by CCL
2026